Trial Profile
Rifaximin in alcoholic hepatitis: effects on inflammatory and metabolic markers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Alcoholic hepatitis
- Focus Pharmacodynamics
- 26 Nov 2018 Status changed from recruiting to completed.
- 05 Jan 2015 New trial record